It is also ideal for assessing the efficacy of various modalities of liver-targeted Pah gene replacement therapies, delivery of Pah mRNA and gene editing techniques such as CRISPR/Cas9 or TALENS, where understanding the level of liver correction via PAH detection is important. The gene discussed is PAH; the disease is pulmonary arterial hypertension.